According to the latest report by IMARC Group, titled “Foot and Mouth Disease (FMD) Vaccine Market Report by Animal Type (Cattle, Pig, Sheep and Goat, and Others), Vaccine Type (Conventional Vaccines, Emergency Vaccines), Distribution Channel (Government Organizations, Distributors/Pharmacies, Private Vet, and Others), and Region 2025-2033,” the global foot and mouth disease (FMD) vaccine market size reached USD 2,270.3 Million in 2024. Foot and mouth disease (FMD) is an infectious animal disease affecting animal species, such as swine, sheep, cattle, and goats. It causes viral fever and blister-like sores on the lips, tongue, and teats; in the mouth; and between the hooves. The vaccine for FMD is nowadays widely used to protect the environment, society, and economy from the devastating impact of the disease. At present, the growing presence of veterinary centers is increasing the demand for FMD vaccines across the globe.
Global Foot and Mouth Disease (FMD) Vaccine Market Trends:
The rising prevalence of FMD, coupled with its socio-economic impact on international trade of animal products, is catalyzing the demand for FMD vaccines worldwide. Apart from this, the burgeoning meat industry and the rising consumption of dairy products are positively influencing the market growth. Furthermore, government bodies of several countries are introducing awareness campaigns for the protection of endangered wildlife species, such as antelopes and bison, against FMD. This, in confluence with the implementation of mandatory norms of cattle rearing, is driving the sales of FMD vaccines to prevent the spread of the disease. Other factors, including the increasing demand for high-grade and disease-free meat, are contributing to the market growth. Looking forward, the market value is projected to reach USD 4,047.3 Million by 2033, expanding at a CAGR of 6.3% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Animal Type, Vaccine Type, Distribution Channel, Region |
Region Covered | Asia Pacific, Latin America, Middle East and Africa, Europe |
Countries Covered | China, India, Bangladesh, Vietnam, Korea, Brazil, Argentina, Nigeria, Ethiopia, Iran, Algeria, Turkey, Georgia, Armenia |
Companies Covered | Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI “Federal Center for Animal Health”, Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800